title: Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study.
authors.affiliation: 1 Endocrinology Section, Medical Service, VA Northern California Health System , Mather, California.|2 Division of Endocrinology, Department of Internal Medicine, UC Davis School of Medicine , Mather, California.
authors.forename: Arthur L M
authors.initials: AL
authors.lastname: Swislocki
authors.affiliation: 1 Endocrinology Section, Medical Service, VA Northern California Health System , Mather, California.
authors.forename: Ishwarlal
authors.initials: I
authors.lastname: Jialal
mesh_terms: D002318:Cardiovascular Diseases; D003924:Diabetes Mellitus, Type 2; D052216:Glucagon-Like Peptide 1 / Q000819:agonists; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007004:Hypoglycemic Agents
chemical_list: D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D052216:Glucagon-Like Peptide 1